Skip to main content

Solid Tumor DNA Content Analysis

  • Protocol
Flow Cytometry Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 263))

Abstract

Flow cytometric DNA content analysis provides a rapid and reliable analysis of DNA ploidy and the proliferative fraction of tumor specimens. Both archival and fresh specimens are suitable for this technique. This information can be used in conjunction with traditional prognostic factors in the biological assessment of certain carcinomas. Among these tumors are early stages of breast, colon, lung, and bladder carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Barlogie, B., Göhde, W., Johnston, D. A., et al. (1978) Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res. 38, 3333–3339.

    PubMed  CAS  Google Scholar 

  2. Barlogie, B., Drewinko, B., Schumann, J., et al. (1980) Cellular DNA content as a marker of neoplasia in man. Am. J. Medicine 69, 195–203.

    Article  CAS  Google Scholar 

  3. Hiddemann, W., Schumann, J., Andreeff, M., et al. (1984) Convention on nomenclature for DNA cytometry. Cytometry 5, 445–446.

    Article  Google Scholar 

  4. Merkel, D. E., Dressler, L. G., and McGuire, W. L. (1987) Flow cytometry, cellular DNA content, and prognosis in human malignancy. J. Clin. Oncol. 5, 1690–1703.

    PubMed  CAS  Google Scholar 

  5. Koss, L. G, Czerniak, B., Herz, F., and Wersto, R. P. (1989) Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum. Pathol. 20, 528–548.

    Article  PubMed  CAS  Google Scholar 

  6. Seckinger, D., Sugarbaker, E., and Frankfurt, O. (1989) DNA content in human cancer. Arch. Pathol. Lab. Med. 113, 619–626.

    PubMed  CAS  Google Scholar 

  7. Shapiro, H. M. (1989) Flow cytometry of DNA content and other indicators of proliferative activity. Arch. Pathol. Lab. Med. 113, 591–597.

    PubMed  CAS  Google Scholar 

  8. Vohn, M. (1989) Prognostic implications of DNA aneuploidy and proliferative activity in solid human tumors. Tumor Diagn. Ther. 10, 229–232.

    Google Scholar 

  9. Raber, M. N. and Barlogie, B. (1990) DNA flow cytometry of human solid tumors, in Flow Cytometry and Cell Sorting, 2nd edit. (Melamed, M. R., Lindmo, T., and Mendelsohn, M. L., eds.), Wiley-Liss, New York, pp. 745–754.

    Google Scholar 

  10. Williams, N. N. and Daly, J. M. (1990) Flow cytometry and prognostic implications in patients with solid tumors. Surgery 171, 257–266.

    CAS  Google Scholar 

  11. Wersto, R. P., Liblit, R. L., and Koss, L. G (1991) Flow cytometric DNA analysis of human solid tumors: a review of the interpretation of DNA histograms. Hum. Pathol. 22, 1085–1098.

    Article  PubMed  CAS  Google Scholar 

  12. Camplejohn, R. S. (1992) Critical summaries, flow cytometry. J. Pathol. 166, 323–326.

    Article  PubMed  CAS  Google Scholar 

  13. El-Naggar, A. K. (1992) Clinical relevance of the flow cytometric analysis in cancer. Cancer J. 5, 321–327.

    Google Scholar 

  14. Sasaki, K. and Murakami, T. (1992) Clinical application of flow cytometry for DNA analysis of solid tumors. Acta Pathol. Jpn. 42, 1–14.

    PubMed  CAS  Google Scholar 

  15. Barlogie, B., McLaughlin, P., and Alexanian, R. (1987) Characterization of hematolgoic malignancies by flow cytometric. Anal. Quant. Cytol. Histol. 9, 147–155.

    PubMed  CAS  Google Scholar 

  16. Andreeff, M. (1990) Flow cytometry of leukemia, in Flow Cytometry and Cell Sorting, 2nd edit. (Melamed, M. R., Lindmo, T., and Mendelsohn, M. L., eds.), Wiley-Liss, New York, pp. 697–724.

    Google Scholar 

  17. Andreeff, M. (1990) Flow cytometry of lymphoma, in Flow Cytometry and Cell Sorting, 2nd edit. (Melamed, M. R., Lindmo, T., and Mendelsohn, M. L., eds.), Wiley-Liss, New York, pp. 725–743.

    Google Scholar 

  18. Hedley, D. W., Shankey T. V., and Wheeless, L. L. (1993) DNA cytometry consensus conference. Cytometry 14, 471.

    PubMed  CAS  Google Scholar 

  19. Shankey, T. V., Rabinovitch, P. S., Bagwell, B., et al. (1993) Guidelines for the implementation of clinical DNA cytometry. Cytometry 14, 472–477.

    Article  PubMed  CAS  Google Scholar 

  20. Wheeless, L. L., Badalament, R. A., de Vere White, R. W., Fradet, Y., and Tribukait, B. (1993) Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 14, 482–485.

    Google Scholar 

  21. Hedley, D. W, Cark, G. M., Cornelisse, C. J., Killander, D., Kute, T., and Merkel, D. (1993) Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 14, 482–485.

    Article  PubMed  CAS  Google Scholar 

  22. Bauer, K. D., Bagwell, C. B., Giaretti, W., et al. (1993) Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 14, 486–491.

    Article  PubMed  CAS  Google Scholar 

  23. Duque, R. E., Andreeff, M., Braylan, R. C, Diamond, L. W., and Peiper, S. C. (1993) Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry 14, 492–496.

    Article  PubMed  CAS  Google Scholar 

  24. Shankey, T. V., Kallioniemi, O.-P., Koslowski, J. M., et al. (1993) Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 14, 497–500.

    Article  PubMed  CAS  Google Scholar 

  25. Kute, T. E., Gregory, B., Galleshaw, J., Hopkins, M., Buss, D., and Case, D. (1988) How reproducible are flow cytometry data from paraffin-embedded blocks? Cytometry 9, 494–498.

    Article  PubMed  CAS  Google Scholar 

  26. Hedley, D. W (1989) Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 10, 229–241.

    Article  PubMed  CAS  Google Scholar 

  27. Joensuu, H. and Kallioniemi, O.-P (1989) Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. Cytometry 10, 711–717.

    Article  PubMed  CAS  Google Scholar 

  28. McLemore, D. D., El-Naggar, A., Stephens, L. C, and Jardine, J. H. (1990) Modified methodology to improve flow cytometric DNA histograms from paraffin-embedded material. Stain. Technol. 65, 279–291.

    PubMed  CAS  Google Scholar 

  29. Arber, D. A. and Speights, V. O. (1991) Aneuploidy in benign seminal vesicle epithelium: an example of the paradox of ploidy studies. Mod. Pathol. 4, 687–689.

    PubMed  CAS  Google Scholar 

  30. Alderision, M., Cenci, M., Valli, C, et al. (1998) Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder. Anticancer Res. 18, 4225–4230.

    Google Scholar 

  31. Gregoire, M., Fradet, Y, Meyer, F, et al. (1997) Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during follow-up for bladder tumors. J. Urol. 157, 660–1664.

    Article  Google Scholar 

  32. Granfors, T., Duchek, M., Tomic, R., Roos, G, and Ljungberg, B. (1996) Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy. Scand. J. Urol. Nephrol. 30, 281–285.

    Article  PubMed  CAS  Google Scholar 

  33. Ross, J. S., Sheehan, C. E., Ambros, R. A., et al. (1999) Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer. Am. J. Surg. Pathol. 161, 296–301.

    Article  Google Scholar 

  34. Amling, C. L., Lerner, S. E., Martin, S. K., Slezak, J. M., Blute, M. L., and Zincke, H. (1999) Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J. Urol. 161, 857–862.

    Article  PubMed  CAS  Google Scholar 

  35. Astrom, L., Weimarck, A., Aldenborg, F., et al. (1998) S-phase fraction related to prognosis in localized prostate cancer. No specific significance of chromosome 7 gain or deletion of 7q31.1. Int. J. Cancer 79, 553–559.

    Article  PubMed  CAS  Google Scholar 

  36. Witzig, T. E., Ingle, N. K., Schaid, D. J., et al. (1993) DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials. J. Clin. Oncol. 11, 351–359.

    PubMed  CAS  Google Scholar 

  37. Romero, H., Schneider, J., Burgos, J., Bilbao, J., and Rodriguez-Escudero, F. J. (1996) S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers. Breast Cancer Res. Treat. 38, 265–275.

    Article  PubMed  CAS  Google Scholar 

  38. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on may 17, 1996 by the American Society of Clinical Oncology [see comments]. (1996) J. Clin. Oncol. 14, 2843–2877.

    Google Scholar 

  39. Wenger, C. R. and Clark, G. M. (1998) S-phase fraction and breast cancer—a decade of experience. Breast Cancer Res. Treat. 51, 255–265.

    Article  PubMed  CAS  Google Scholar 

  40. Giella, J. G., Ring, K., Olsson, C. A., Karp, F. S., and Benson, M. C. (1992) The predictive value of flow cytometry and urinary cytology in the follow-up of patients with transitional cell carcinoma of the bladder. J. Urol. 148, 293–296.

    PubMed  CAS  Google Scholar 

  41. Wheeless, L. L., Badalament, R. A., de Vere White, R. W., Fradet, Y., and Tribukait, B. (1993) Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. Cytometry 14, 478–481.

    Google Scholar 

  42. Reles, A. E., Gee, G, Schellschmidt, I., et al. (1998) Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry [see also comments]. Gynecol. Oncol. 71, 3–13.

    Article  PubMed  CAS  Google Scholar 

  43. Zanetta, G, Keeney, G L., Cha, S. S., Wieand, H. S., Katzmann, J. A., and Podratz, K. C. (1996) DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation. Gynecol. Oncol. 74, 208–212.

    Article  Google Scholar 

  44. Muguerza, J. M., Diez, M., Torres, A. J., et al. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: rationale of sequential processing of frozen and paraffin-embedded tissue. World J. Surg. 21, 323–329.

    Google Scholar 

  45. Roberts, H. L., Komaki, R., Allen, P., and El-Naggar, A. K. (1998) Prognostic significance of DNA content in stage I adenocarcinoma of the lung. Int. J. Rad. Oncol. Biol. Phys. 41, 573–578.

    Article  CAS  Google Scholar 

  46. Karlsson, M., Boeryd, B., Carstensen, J., et al. (1996) Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J. Cancer 32A, 357–362.

    Article  PubMed  CAS  Google Scholar 

  47. Lanza, G., Gafa, R., Santini, A., et al. (1998) Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer 82, 49–59.

    Article  PubMed  CAS  Google Scholar 

  48. Nervi, C, Badaracco, G., Maisto, A., Mauro, F., Tirindelli-Danesi, D., and Starace, G (1982) Cytometric evidence of cytogenetic and proliferative heterogeneity in human solid tumors. Cytometry 2, 303–308.

    Article  PubMed  CAS  Google Scholar 

  49. Kallioniemi, O.-P. (1988) Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 9, 164–169.

    Article  PubMed  CAS  Google Scholar 

  50. van der Linden, J. C, Herman, C. J., Boenders, J. G, van de Sandt, M. M., and Lindeman, J. (1992) Flow cytometric DNA content of fresh tumor specimens using keratin-antibody as second stain for two parameter analysis. Cytometry 13, 163–168.

    Article  PubMed  Google Scholar 

  51. Frei, J. V. and Martinez, V. J. (1993) DNA flow cytometry of fresh and paraffin-embedded tissue using cytokeratin staining. Mod. Pathol. 6, 599–605.

    PubMed  CAS  Google Scholar 

  52. Park, C. H. and Kimler, B. F (1994) Tumor cell-selective flow cytometric analysis for DNA content and cytokeratin expression of clinical tumor specimens by “cross-gating.” Anticancer Res. 14, 29–36.

    PubMed  CAS  Google Scholar 

  53. Kenyon, N. S., Schmitting, R. J., Siiman, O., Burshteyn, A., and Bolton, W. E. (1994) Enhanced assessment of DNA/proliferative index by depletion of tumor infiltrating leukocytes prior to monoclonal antibody gated analysis of tumor cell DNA. Cytometry 16, 175–183.

    Article  PubMed  CAS  Google Scholar 

  54. Zarbo, R. J., Brown, R. D., Linden, M. D., Torres, F X., Nakhleh, R. E., and Schultz, D. S. (1994) Rapid (one-shot) staining method for two-color multipara-metric DNA flow cytometric analysis of carcinoma using staining for cytokeratin and leukocyte common antigen. Am. J. Clin. Pathol. 101, 638–642.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc.

About this protocol

Cite this protocol

El-Naggar, A.K., Vielh, P. (2004). Solid Tumor DNA Content Analysis. In: Hawley, T.S., Hawley, R.G. (eds) Flow Cytometry Protocols. Methods in Molecular Biology™, vol 263. Humana Press. https://doi.org/10.1385/1-59259-773-4:355

Download citation

  • DOI: https://doi.org/10.1385/1-59259-773-4:355

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-234-6

  • Online ISBN: 978-1-59259-773-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics